NSPR Stock Price & Analysis — Inspiremd Inc (Healthcare >> Medical Devices)
NSPR FAQ
What is NSPR's P/E ratio?
Inspiremd Inc (NSPR) currently trades at a P/E ratio of 108.88.
What is NSPR's ROE?
Inspiremd Inc reports a Return on Equity (ROE) of -85.59%.
What is NSPR's dividend yield?
Inspiremd Inc offers a dividend yield of 0.00%.
What is NSPR's Quality Score?
Our AI rates NSPR's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy NSPR?
Our AI Timing Score for NSPR is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does NSPR belong to?
Inspiremd Inc is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange
NSPR AI Analysis Summary
Our AI summary for NSPR: Inspiremd Inc (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 108.88, ROE of -85.59%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 0/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 0.65
Price
-0.02
(-3.25%)
Day Change
|
|
|---|
NSPR, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 92 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.65 |
| PBV / Sector |
0.72 / -101.57
GREAT
|
| Earning Per Share | -0.77 |
| PE / Sector |
108.88 / 31.23
|
| PEG or PE/Growth / Sector |
-3.84 / 0.40
|
| Average 1M Daily Value |
0.04 M
GREAT
|
| Average 1W Daily Value |
0.03 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
60% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-01 08:00:14 |
| Symbol | NSPR |
| Name | INSPIREMD INC |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 46.84 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 31.47 / 20,104.97 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 6303 Waterford District Drive, Miami, FL, United States, 33126
Phone: 888 776 6804
Website: https://www.inspiremd.com
Employees: 127
Sector: Healthcare >> Medical Devices
Description: InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
Google